UgisGruntmanisMD

Endocrinology • Lebanon, NH

Diabetes, Lipid Metabolism

Professor of Endocrinology, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Gruntmanis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gruntmanis' full profile

Already have an account?

Office
1 Medical Dr
Lebanon, NH 03756
Phone+1 603-650-8630

Education & Training

Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2001
University of RochesterResidency, Internal Medicine, 1997 - 1999
Yale-New Haven Medical CenterInternship, Internal Medicine, 1996 - 1997
Latvian Medical AcademyClass of 1992

Certifications & Licensure

CA State Medical License 1999 - Present
NH State Medical License 2020 - 2026
VT State Medical License 2022 - 2026
TX State Medical License 2001 - 2022
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Publications & Presentations

PubMed

144 citations
Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone ...
Maria T. Abreu, Vitaly Kantorovich, Eric A. Vasiliauskas, Ugis Gruntmanis, R Matuk
Gut. 2004-08-01
126 citations
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density
Eric S. Orwoll, Christence S. Teglbjaerg, Bente L. Langdahl, Roland Chapurlat, Edward Czerwiński
The Journal of Clinical Endocrinology and Metabolism. 2012-06-21
71 citations
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
Bente L. Langdahl, Christence S. Teglbjaerg, P.R. Ho, Roland Chapurlat, Edward Czerwiński
The Journal of Clinical Endocrinology and Metabolism. 2015-01-21

Press Mentions

Clinical Experience with Intravenous Zoledronic Acid in the Treatment of Male Osteoporosis: Evidence and OpinionsAugust 1st, 2013